Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cue Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CUE
Nasdaq
8731
https://www.cuebiopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cue Biopharma Inc
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
- Nov 22nd, 2023 1:00 pm
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 5:55 pm
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
- Nov 9th, 2023 9:05 pm
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
- Nov 7th, 2023 1:00 pm
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
- Nov 3rd, 2023 4:00 pm
Cue Biopharma to Host Business Update Call and Webcast
- Nov 2nd, 2023 12:00 pm
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?
- Sep 28th, 2023 9:39 am
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
- Sep 27th, 2023 1:05 pm
Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®
- Sep 26th, 2023 12:00 pm
Q2 2023 Cue Biopharma Inc Earnings Call
- Aug 10th, 2023 2:37 pm
Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2023 Earnings Call Transcript
- Aug 10th, 2023 2:19 pm
Investors in Cue Biopharma (NASDAQ:CUE) have unfortunately lost 83% over the last three years
- Aug 10th, 2023 12:28 pm
Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
- Aug 9th, 2023 8:10 pm
3 Biotech Stocks to Buy as Companies Ink Major Deals
- Jun 22nd, 2023 10:40 am
Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting
- Jun 14th, 2023 12:00 pm
Cue Biopharma to Host Investor Call
- Jun 7th, 2023 12:00 pm
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
- Jun 5th, 2023 12:00 pm
3 Biotech Stocks Sitting on Huge-Upside Catalysts
- May 26th, 2023 10:19 am
Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- May 25th, 2023 9:00 pm
Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- May 15th, 2023 12:00 pm
Scroll